#  Research Seminar Series—Neuropilin-2 Promotes Oral Carcinogenesis by Stimulating Tumor Growth and Angiogenesis While Suppressing Tumor Immunity 

 



    ![decorative](/sites/g/files/omnuum6001/files/styles/hwp_5_4__480x385/public/2026-09/AdobeStock_813958176.jpg?itok=yhlvomKo) 

 



 

####  calendar\_today Date and Time 

 **September 23, 2026** 

 12:00PM - 01:00PM EDT 

####  pin\_drop Location 

 **REB 109 and Zoom**  



 

 [ Register arrow\_circle\_right ](https://harvard.zoom.us/webinar/register/WN_LkezRHs9QymqkDMhIzhvNQ#/registration) 

 



 

Join us for the next Research Seminar Series featuring Dr. Diane Bielenberg, whose laboratory investigates how neuropilin receptors influence oral cancer, immune surveillance, blood vessel formation, inflammation, and other disease processes. Learn how this research is advancing the understanding of cancer and other complex conditions.

*Lunch will be provided.*

---

   ![headshot](/sites/g/files/omnuum6001/files/styles/hwp_1_1__360x360_scale/public/2026-09/Diane-Bielenberg-headshot.jpg?itok=1-neITg_) 

 

## About the speaker

Dr. Diane Bielenberg is an assistant professor in the Department of Surgery at Harvard Medical School and a principal investigator in the Vascular Biology Program at Boston Children’s Hospital. Her laboratory studies the role of neuropilin receptors in neovascularization, lymphatic drainage, smooth muscle tone, inflammation, and carcinogenesis. This translational research has implications for hypertension, lymphedema, smooth muscle motility disorders, obesity, cancer, and chronic inflammation.



 

 



 

 See also:- [ Homepage ](/home-page/homepage)
- [ Research ](/news-categories/research)
 
 

 Save: [ Add to calendar calendar\_today ](https://www.hsdm.harvard.edu/node/1597386/event-feed.ics)  Copy link link